Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines

Dong Kyun Woo, Hee Sung Kim, Hye Seung Lee, Young Hwa Kang, Han Kwang Yang, Woo Ho Kim

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

β-Catenin serves not only as a structural component of the E-cadherin-mediated cell-cell adhesion system, but also as a signaling molecule of the Wnt/wingless pathway. Deregulated expression of β-catenin and mutations of the gene have been identified in a number of human malignancies. To determine the role of β-catenin defects in stomach cancer, we investigated β-catenin exon 3 mutations and altered protein expression in 77 primary gastric carcinomas and 11 cell lines. In addition, the immunohistochemical expression pattern of β-catenin in 303 consecutive gastric cancers was determined and their relationships with clinicopathologic features and patient outcome were investigated. This study revealed 5% (4 of 77) tumors and 27% (3 of 11) cell lines with β-catenin gene alteration, 6 missense mutations, and I interstitial deletion. These genetic changes were shown to correlate closely with nuclear localization of the protein (p = 0.001). In an immunohistochemical analysis, abnormal expressions of β-catenin, such as nuclear accumulation and loss of membranous distribution, were detected in 27% (81 of 303) of tumors overall. These altered β-catenin expressions were more commonly observed in 37% (58 of 158) diffuse type gastric carcinomas (p < 0.001). Loss of membranous β-catenin staining was associated with poor survival (p = 0.045). In conclusion, our results demonstrate that β-catenin mutations are common in gastric cancer cell lines but occur infrequently in gastric carcinoma tissues. These mutations are one of the causes of the nuclear accumulation of β-catenin. Frequent abnormalities of β-catenin expression in gastric carcinoma support the idea that both structural and signaling functions of the protein play a critical role in gastric carcinogenesis.

Original languageEnglish
Pages (from-to)108-113
Number of pages6
JournalInternational Journal of Cancer
Volume95
Issue number2
DOIs
StatePublished - 20 Mar 2001

Fingerprint

Catenins
Stomach
Carcinoma
Cell Line
Mutation
Genes
Stomach Neoplasms
Neoplasms
Wnt Signaling Pathway
Missense Mutation
Cadherins
Nuclear Proteins
Cell Adhesion
Exons
Carcinogenesis
Proteins

Keywords

  • Beta-catenin
  • Cytoskeletal proteins
  • Immunohistochemistry
  • Mutation
  • Prognosis
  • Stomach neoplasm

Cite this

@article{1854700ba9554868b4781bcac2cc6d4f,
title = "Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines",
abstract = "β-Catenin serves not only as a structural component of the E-cadherin-mediated cell-cell adhesion system, but also as a signaling molecule of the Wnt/wingless pathway. Deregulated expression of β-catenin and mutations of the gene have been identified in a number of human malignancies. To determine the role of β-catenin defects in stomach cancer, we investigated β-catenin exon 3 mutations and altered protein expression in 77 primary gastric carcinomas and 11 cell lines. In addition, the immunohistochemical expression pattern of β-catenin in 303 consecutive gastric cancers was determined and their relationships with clinicopathologic features and patient outcome were investigated. This study revealed 5{\%} (4 of 77) tumors and 27{\%} (3 of 11) cell lines with β-catenin gene alteration, 6 missense mutations, and I interstitial deletion. These genetic changes were shown to correlate closely with nuclear localization of the protein (p = 0.001). In an immunohistochemical analysis, abnormal expressions of β-catenin, such as nuclear accumulation and loss of membranous distribution, were detected in 27{\%} (81 of 303) of tumors overall. These altered β-catenin expressions were more commonly observed in 37{\%} (58 of 158) diffuse type gastric carcinomas (p < 0.001). Loss of membranous β-catenin staining was associated with poor survival (p = 0.045). In conclusion, our results demonstrate that β-catenin mutations are common in gastric cancer cell lines but occur infrequently in gastric carcinoma tissues. These mutations are one of the causes of the nuclear accumulation of β-catenin. Frequent abnormalities of β-catenin expression in gastric carcinoma support the idea that both structural and signaling functions of the protein play a critical role in gastric carcinogenesis.",
keywords = "Beta-catenin, Cytoskeletal proteins, Immunohistochemistry, Mutation, Prognosis, Stomach neoplasm",
author = "Woo, {Dong Kyun} and Kim, {Hee Sung} and Lee, {Hye Seung} and Kang, {Young Hwa} and Yang, {Han Kwang} and Kim, {Woo Ho}",
year = "2001",
month = "3",
day = "20",
doi = "10.1002/1097-0215(20010320)95:2<108::aid-ijc1019>3.0.co;2-{\%}23",
language = "English",
volume = "95",
pages = "108--113",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines. / Woo, Dong Kyun; Kim, Hee Sung; Lee, Hye Seung; Kang, Young Hwa; Yang, Han Kwang; Kim, Woo Ho.

In: International Journal of Cancer, Vol. 95, No. 2, 20.03.2001, p. 108-113.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines

AU - Woo, Dong Kyun

AU - Kim, Hee Sung

AU - Lee, Hye Seung

AU - Kang, Young Hwa

AU - Yang, Han Kwang

AU - Kim, Woo Ho

PY - 2001/3/20

Y1 - 2001/3/20

N2 - β-Catenin serves not only as a structural component of the E-cadherin-mediated cell-cell adhesion system, but also as a signaling molecule of the Wnt/wingless pathway. Deregulated expression of β-catenin and mutations of the gene have been identified in a number of human malignancies. To determine the role of β-catenin defects in stomach cancer, we investigated β-catenin exon 3 mutations and altered protein expression in 77 primary gastric carcinomas and 11 cell lines. In addition, the immunohistochemical expression pattern of β-catenin in 303 consecutive gastric cancers was determined and their relationships with clinicopathologic features and patient outcome were investigated. This study revealed 5% (4 of 77) tumors and 27% (3 of 11) cell lines with β-catenin gene alteration, 6 missense mutations, and I interstitial deletion. These genetic changes were shown to correlate closely with nuclear localization of the protein (p = 0.001). In an immunohistochemical analysis, abnormal expressions of β-catenin, such as nuclear accumulation and loss of membranous distribution, were detected in 27% (81 of 303) of tumors overall. These altered β-catenin expressions were more commonly observed in 37% (58 of 158) diffuse type gastric carcinomas (p < 0.001). Loss of membranous β-catenin staining was associated with poor survival (p = 0.045). In conclusion, our results demonstrate that β-catenin mutations are common in gastric cancer cell lines but occur infrequently in gastric carcinoma tissues. These mutations are one of the causes of the nuclear accumulation of β-catenin. Frequent abnormalities of β-catenin expression in gastric carcinoma support the idea that both structural and signaling functions of the protein play a critical role in gastric carcinogenesis.

AB - β-Catenin serves not only as a structural component of the E-cadherin-mediated cell-cell adhesion system, but also as a signaling molecule of the Wnt/wingless pathway. Deregulated expression of β-catenin and mutations of the gene have been identified in a number of human malignancies. To determine the role of β-catenin defects in stomach cancer, we investigated β-catenin exon 3 mutations and altered protein expression in 77 primary gastric carcinomas and 11 cell lines. In addition, the immunohistochemical expression pattern of β-catenin in 303 consecutive gastric cancers was determined and their relationships with clinicopathologic features and patient outcome were investigated. This study revealed 5% (4 of 77) tumors and 27% (3 of 11) cell lines with β-catenin gene alteration, 6 missense mutations, and I interstitial deletion. These genetic changes were shown to correlate closely with nuclear localization of the protein (p = 0.001). In an immunohistochemical analysis, abnormal expressions of β-catenin, such as nuclear accumulation and loss of membranous distribution, were detected in 27% (81 of 303) of tumors overall. These altered β-catenin expressions were more commonly observed in 37% (58 of 158) diffuse type gastric carcinomas (p < 0.001). Loss of membranous β-catenin staining was associated with poor survival (p = 0.045). In conclusion, our results demonstrate that β-catenin mutations are common in gastric cancer cell lines but occur infrequently in gastric carcinoma tissues. These mutations are one of the causes of the nuclear accumulation of β-catenin. Frequent abnormalities of β-catenin expression in gastric carcinoma support the idea that both structural and signaling functions of the protein play a critical role in gastric carcinogenesis.

KW - Beta-catenin

KW - Cytoskeletal proteins

KW - Immunohistochemistry

KW - Mutation

KW - Prognosis

KW - Stomach neoplasm

UR - http://www.scopus.com/inward/record.url?scp=0035916970&partnerID=8YFLogxK

U2 - 10.1002/1097-0215(20010320)95:2<108::aid-ijc1019>3.0.co;2-%23

DO - 10.1002/1097-0215(20010320)95:2<108::aid-ijc1019>3.0.co;2-%23

M3 - Article

C2 - 11241321

AN - SCOPUS:0035916970

VL - 95

SP - 108

EP - 113

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -